Table 1.

Summary of cases used in the present study.

No	Diagnosis	Gender	Age	PM delay	RIN	PCR	WB	ELISA	MA	MI
1	MA	Male	64	8 h 30 min	7.7	X	X	X
2	MA	Male	56	5 h	7.1	X	X	X	X	X
3	MA	Male	67	5 h	7	X	X	X	X
4	MA	Male	62	3 h	7.2	X	X	X	X	X
5	MA	Male	52	4 h 40 min	7.9	X	X	X		X
6	MA	Male	30	4 h 10 min	8.4	X	X	X	X
7	MA	Male	53	3 h	7.7	X	X	X		X
8	MA	Female	49	7 h	8.2	X	X	X
9	MA	Female	75	3 h	6.5	X	X	X
10	MA	Female	46	9 h 35 min	7.2	X	X	X	X
11	MA	Female	86	4 h 15 min	8.4	X	X	X
12	MA	Female	79	3 h 35 min	8	X	X	X
13	DLB	Male	81	7 h	5.3	X	X	X
14	DLB	Female	78	5 h	5.7	X	X	X		X
15	DLB	Male	76	5 h 10 min	5.2	X	X	X		X
16	DLB	Male	83	9 h	5.2	X	X	X	X	X
17	DLB	Male	78	8 h 30 min	6.3	X	X	X
18	DLB	Male	64	8 h 15 min	7	X	X	X	X
19	DLB	Male	80	8 h	6.1	X	X	X		X
20	DLB	Male	77	7 h 20 min	6.4	X	X	X
21	DLB	Male	71	9 h	7	X	X	X	X
22	rpDLB	Female	75	13 h 30 min	5.6	X	X	X	X	X
23	rpDLB	Male	76	6 h 30 min	5.5	X	X	X	X	X
24	rpDLB	Male	71	5 h	5	X	X	X	X	X
25	rpDLB	Female	73	15 h 30 min	6.1	X	X	X		X

MA, middle-aged cases with no neurological disease and neuropathological lesions limited to Alzheimer’s disease-related pathology stages I–II/0–A of Braak and phases 1–2 of β-amyloid plaques; mean age ± SD was 59.92 ± 15.60. DLB cases were older with no differences between DLB (76.44 ± 5.77) and rpDLB (73.75 ± 2.22). DLB, the term DLB is used to name clinically and neuropathologically verified dementia with Lewy bodies, whereas rpDLB indicates DLB with rapid course. PM delay, postmortem delay; RIN, RNA integrity number; PCR, implies the use of these samples for gene expression studies; WB, cases analyzed with western blotting; ELISA, enzyme-linked immunosorbent assay; MA, mitochondrial enzyme activities; MI, study of α-synuclein oligomeric species in total homogenate fractions. RIN median: 7. Ratio RIN min/max: 5/8.4. PM delay median: 6 h 30 m. PM delay: min/max: 3/15 h 30 m.